Ibrokhim Y. Abdurakhmonov

Center of Genomics and Bioinformatics, Academy of Sciences of Uzbekistan

Ibrokhim Y. Abdurakhmonov received his BS in Biotechnology (1997) from the National University, Uzbekistan, an MS in Plant Breeding (2001) from Texas A&M University, and a Ph.D. in Molecular Genetics (2002) and DSc in Genetics (2009) from the Academy of Sciences of Uzbekistan. He became a full professor at the same university in 2011. He founded the Center of Genomics and Bioinformatics of Uzbekistan in 2012. Dr. Abdurakhmonov was elected as a fellow of The World Academy of Sciences (TWAS) in 2014 and a member of the Academy of Sciences of Uzbekistan in 2017. He served as Uzbekistan\'s Minister of Innovative Development from 2017 to 2022. He served as Uzbekistan\'s Minister of Higher Education, Science, and Innovations from 2022 to 2023. He received the 2010 TWAS prize and ICAC Cotton Researcher of the Year 2013 for his outstanding contribution to cotton genomics and biotechnology. He was honored as the 2022 Ambassador of Silk Road Friendship (Individual) by the China International Culture Exchange Center (CICEC) and Global People Magazine. He received the 2023 UNESCO-Equatorial Guinea International Prize for Research in the Life Sciences for developing molecular markers that can be used to identify desirable traits in cotton, such as disease resistance, fiber quality, and yield. For his joint contribution to COVID-19 vaccine development, he received the 8th Zhongyuan Union Life Medicine International Cooperation Award in 2023, presented by the UCAS and VCANBIO Cell& Gene Engineering Corporation, China. In 2023, he was appointed as Minister of Agriculture of Uzbekistan.

Ibrokhim Y. Abdurakhmonov

15books edited

16chapters authored

Latest work with IntechOpen by Ibrokhim Y. Abdurakhmonov

COVID-19 Vaccines - Current State and Perspectives provides the reader with the latest overview and opinions on the current state of the art in COVID-19 vaccines, as well as future prospects. The challenges covered include novel vaccine development for the emerging variants of concern (VOCs), vaccine side-effects with real-world examples, population hesitancy, and country experiences with COVID-19 vaccine development, clinical trialing and mass vaccination. Chapters discuss new opinions and directions on the repurposing of existing traditional vaccines with a wide spectrum of action and new platforms for fast-tracked vaccine production and approvals.

Go to the book